药理学-英文版-留学生与双语教学用_PDF下载[158MB-百度云]娄建石

本书特色

[

　　娄建石主编的《药理学（留学生与双语教学用英文版）》系统地介绍了药理学的基本知识，包括常用药物的作用和原理、临床应用、不良反应以及药物相互作用等。内容简明易懂，适合临床医学专业学生初步学习药理学的入门教材，也可作为其他医学相关专业学生学习药理学的教材，如护理学、口腔医学、麻醉学、中西医结合医学、医学检验、医学影像、公共卫生和药学专业等。本书也可供医药卫生专业工作人员学习和应用药理学的参考教材。

]

chapter 1 introduction i. development of pharmacology ii. new drug researchchapter 2 pharmacodynamics i. general classification of drug effects ii. dose-effect relationship iii. receptor theory and drug receptor interaction iv. receptor families and their transducer and effector molecules v. relationship between regulatory mechanisms of receptors and the pharmacological action vi. mechanism of actionchapter 3 pharmacokinetics i. drug transport across membranes ii. the dynamics of drug absorption, distribution, and elimination ii. general principles of pharmacokineticschapter 4 pharmacogenetics i. the objectives of research in pharmacogenetics ii. the effect of genetic factors on drug reactions iii. the racial difference of drug reaction and metabolismchapter 5 autonomic pharmacology i. anatomy and neurotransmitter chemistry of the autonomic nervous system ii. biosynthesis and metabolism of transmitters iii. locations of autonomic receptors iv. presynaptic regulation of transmitter release v. functional organization of autonomic activity vi. coupling mechanism of receptor-effect vii. mode of action of autonomic nervous system drugs viii. classification of autonomic nervous system drugschapter 6 cholinoceptor-activating and cholinesterase-lnhibiting drugs i. direct-acting cholinoceptor stimulants ii. cholinesterase inhibitorschapter 7 organophosphates anticho:inesterase intoxication and cholinesterase reactivators… i. organophosphates anticholinesterase intoxication ii. cholinesterase reactivatorchapter 8 m cholinoceptorantagonists i. natural m cholinoceptor blocking drugs ii. synthetic spasmolytic drugschapter 9 n cholinoceptorantagonists i. n1 cholinoceptor blocking drugs ii. n2 cholinoceptor blocking drugschapter 10 adrenoceptor-activating drugs i. chemical structure ii. classification iii. mixed α and β receptor agonists iv. α receptor agonists v. β receptor agonists vi. dopaminergic receptor agonistschapter 11 adrenoceptor blocking drugs i. a receptor antagonists ii. β receptor antagonists iii. a, β receptor antagonistschapter 12 sedative-hypnotics drugs i. introduction ii. benzodiazepines iii. barbiturates iv. other sedative-hypnoticschapter 13 antiepileptic drugs i. classification of seizure types ii. drugs used in seizures iii. selectivity and withdrawal of antiepileptic drugs iv. anticonvulsant drugschapter 14 psychotropic drugs i. antipsychotic drugs ii. antimanic drugs iii. antidepressantschapter 15 antiparkinsonism drugs i. dopaminergic drugs ii. anticholinergic drugs iii. otherschapter 16 antipyretic-analgesic and antiinflammatory drugs i. introduction ii. salicylates iii. anilines iv. pyrazolones v. others vi. analgesic compounds vii. slow acting antirheumatic drugs viii. antigout drugschapter 17 narcotic analgesics i. introduction ii. opioid receptor agonists iii. opioid receptor antagonistschapter 18 central stimulants i. cerebral stimulants ii. medullary stimulantschapter 19 drugs used in the treatment of heart failure i. pathophysiology of congestive heart failure ii. diuretics lii. aldosterone antagonists iv. inhibitors of raas: acei and at1 receptor antagonists v. β adrenergic receptor blocking agents vi. vasodilators vii. cardiac glycosides vs. [3 adrenergic receptor stimulators ix. phosphodiesterase inhibitorschapter 20 antihypertensive drugs |. introduction ii. drugs that alter sodium and water balance ill. drugs that alter sympathetic nervous system function iv. vasodilators v. drugs that interfere with the renin-angiotensin system vi. clinical pharmacology of antihypertensive drugschapter 21 anti-angina pectoris drugs i. introduction ii. nitrates and nitrites iii. calcium channel blockers iv. /3 receptor antagonistschapter 22 antiarrhythmic drugs i. introduction ii. class i a iii. class i b iv. class i c v. class ii vi. class iii vii. class iv viii. otherschapter 23 autihyperlipidemic drugs i. atherogenesis ii. lipoprotein transport iii. dyslipidaemia iv. antihyperlipidemic drugschapter 24 diuretic and dehydrant drugs i. kidney structure and function ii. diuretics iii. osmotic diuretics (mannitol, sorbitol, glucose, urea)chapter 25 antiasthmatie drugs i. bronchodilators ii. anti-inflammatory drugschapter 26 drugs used in gastrointestinal diseases i. drugs used to treat peptic ulcer 1i. antiemetic drugs iii. antidiarrheal drugs iv. laxatives.chapter 27 drugs affecting uterine motility i. drugs that stimulate uterine contraction ii. drugs that inhibit uterine contractionchapter 28 anticoagulants and coagulants i. introduction ii. anticoagulants iii. antiplatelet drugs iv. fibrinolytic drugs v. coagulantschapter 29 histamine and antihistamine drugs i. histamine ii. h1 receptor antagonists iii. h2 receptor antagonistschapter 30 adrenocorticosteroids i. introduction ii. glucocorticoids iii. mineralocorticoidschapter 31 drugs affecting the thyroid gland i . thyroid hormone (th) ii. antithyroid drugschapter 32 antidiabetic drugs i. insulin ii. oral hypoglycemic drugs iii. current treatment optionschapter 33 introduction to antibacterial drugs i. specialty terms h. antimicrobial mechanisms iii. mechanism of resistance to antibioticschapter 34 syntheticantimicrobial drugs i. sulfonamides ii. trimethoprim iii. quinoloneschapter 35 β-lactam antibiotics i. penicillins ii. cephalosporins iii. other β-lactam drugschapter 36 macrolides, lincosamides and glycopeptides i. macrolides ii. lincosamides iii. glycopeptideschapter 37 broad-spectrum antibiotics i. tetracyclines ii. chloramphenicolschapter 38 aminoglycosides and polypeptides i. aminoglycosides ii. polypeptideschapter 39 antifungal drugs i. antibiotics ii. azole antifungal drugs 11i. allylamine antifungal drugs iv. pyrimidine antifungal drugschapter 40 antiviral drugs i. anti-human immunodeficiency virus drugs ii. anti-herpersvirus drugs iii. anti-influenza drugs iv. anti-hepacivirus drugschapter 41 antimycobacterial drugs i. introduction ii. first-line drugs used in tuberculosis iii. alternative second-line drugs in treatment of tuberculosis iv. combination chemotherapy of tuberculosischapter 42 antimalarial drugs i. plasmodium life cycles and action of antimalarial drugs ii. antimalarial drugs mainly applied to control symptoms iii. antimalarial drugs mainly applied to control relapse and transmission iv. antimalarial drugs mainly applied to causal prophylaxischapter 43 amebicides i. life cycles of entamoeba histolytica and action of amebicides ii. luminal amebicides iii. extraintestinal amebicides iv. luminal and simultaneously extraintestinal amebicideschapter 44 anthelmintic drugs i. nematocides ii. taeniacides iii. anti-trematode drugschapter 45 antineoplastic drugs i. introduction ii. cytotoxic drugs iii. non-cytotoxic drugsreferences